Auven Therapeutics is a private equity company focused on the healthcare industry. The Company's strategy is to acquire controlling ownership in promising therapeutic products or platforms. The value of these therapeutic assets is then significantly enhanced by global development programs prior to selling them as clinically and commercially validated products to established pharmaceutical companies. Auven Therapeutics has built a diversified portfolio of biologic and small molecule therapeutic candidates for a wide range of therapeutic indications. The Company's existing pipeline addresses critical unmet medical needs in cancer, ophthalmic conditions, women's health and orphan diseases. It has ownership of or a controlling interest in the therapeutic assets of ADC Therapeutics, Spirogen, Resolvyx and Kiacta, and a minority investment in Kolltan and Sprout Pharmaceuticals. Founded in 2007 by industry veterans Stephen Evans-Freke and Dr. Peter B. Corr, Auven Therapeutics Management L.L.L.P. is an investment advisor with its principal place of business in the US Virgin Islands. It manages Auven Therapeutics Holdings L.P., a private equity fund, which has its registered office and principal place of business in the British Virgin Islands. Auven Therapeutics Development, the operating company of Auven Therapeutics Holdings L.P. manages drug development from its bases in Lausanne, Switzerland, New York, USA and Hamilton, Bermuda. Auven Therapeutics is an investment advisor with its principal place of business in the US Virgin Islands. It manages Auven Therapeutics Holdings L.P., a private equity fund, which has its registered office and principal place of business in the British Virgin Islands. Auven Therapeutics Development, the operating company of Auven Therapeutics Management L.L.L.P. Holdings L.P. manages drug development from its bases in Lausanne, Switzerland, New York, USA and Hamilton, Bermuda.Based in Delray Beach, FL, Auven Therapeutics is a small professional company with only 175 employees and an annual revenue of $12.0M.
Auven Therapeutics's mission statement
To provide the gold standard in drug development, progressing promising therapeutic pharmaceutical candidates in areas of unmet medical need.
In demand companies are hiring! Let Zippia apply for you!
-
Auven Therapeutics employee reviews
Be the first to review!
Do you work at Auven Therapeutics?
Help job seekers learn about working at Auven Therapeutics
Auven Therapeutics is ranked #17 on the Best companies to work for in Delray Beach, FL list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.
Zippia gives an in-depth look into the details of Auven Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Auven Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Auven Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Auven Therapeutics. The data presented on this page does not represent the view of Auven Therapeutics and its employees or that of Zippia.
Auven Therapeutics may also be known as or be related to Auven Therapeutics.